Omnicell (OMCL) financial statements
Omnicell reported revenue of $1.2B in fiscal 2025, up 6.1% a year over 9 years.
Net income was $2M and the operating margin 0.4%, against 3.1% in 2016.
Free cash flow was $87M, and the company returned $78M in net buybacks.
The diluted share count rose 26% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Omnicell's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $696M | $713M | $787M | $897M | $892M | $1.1B | $1.3B | $1.1B | $1.1B | $1.2B |
| Cost of revenue | $379M | $394M | $415M | $460M | $479M | $577M | $707M | $650M | $641M | $681M |
| Gross profit | $317M | $319M | $372M | $437M | $413M | $555M | $589M | $497M | $471M | $503M |
| Research and development | $58M | $66M | $65M | $69M | $70M | $76M | $105M | $97M | $90M | $89M |
| Selling, general and admin | $238M | $241M | $263M | $290M | $308M | $389M | $486M | $435M | $380M | $410M |
| Operating income | $21M | $11M | $44M | $78M | $36M | $90M | -$2M | -$35M | $337,000 | $5M |
| Interest expense | $5M | $6M | $8M | $4M | — | — | — | — | — | — |
| Pre-tax income | $13M | $5M | $36M | $74M | $29M | $66M | -$2M | -$20M | $26M | $11M |
| Income tax | $3M | -$26M | -$2M | $13M | -$3M | -$12M | -$8M | $263,000 | $13M | $9M |
| Net income | $10M | $31M | $38M | $61M | $32M | $78M | $6M | -$20M | $13M | $2M |
| EPS (diluted) | $0.26 | $0.79 | $0.93 | $1.43 | $0.74 | $1.62 | $0.12 | -$0.45 | $0.27 | $0.04 |
| Diluted shares | 37M | 39M | 41M | 43M | 44M | 48M | 46M | 45M | 46M | 46M |
| Gross margin | 45.6% | 44.7% | 47.3% | 48.7% | 46.3% | 49.0% | 45.4% | 43.3% | 42.3% | 42.5% |
| Operating margin | 3.1% | 1.6% | 5.6% | 8.7% | 4.0% | 7.9% | -0.2% | -3.0% | 0.0% | 0.4% |
| Net margin | 1.4% | 4.3% | 4.8% | 6.8% | 3.6% | 6.9% | 0.4% | -1.8% | 1.1% | 0.2% |
Balance sheet
Fiscal years, from Omnicell's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $54M | $32M | $67M | $127M | $486M | $349M | $330M | $468M | $369M | $197M |
| Receivables | $150M | $190M | $196M | $218M | $190M | $241M | $299M | $252M | $256M | $217M |
| Inventory | $69M | $96M | $101M | $108M | $96M | $120M | $148M | $110M | $89M | $101M |
| Total current assets | $315M | $352M | $397M | $483M | $829M | $781M | $882M | $928M | $815M | $680M |
| Property, plant and equipment | $42M | $43M | $52M | $54M | $59M | $71M | $94M | $109M | $113M | $120M |
| Goodwill | $328M | $338M | $336M | $337M | $499M | $739M | $734M | $736M | $735M | $738M |
| Total assets | $935M | $1.0B | $1.1B | $1.2B | $1.8B | $2.1B | $2.2B | $2.2B | $2.1B | $2.0B |
| Total current liabilities | $181M | $205M | $205M | $237M | $276M | $876M | $428M | $368M | $596M | $477M |
| Long-term debt | $246M | $195M | $135M | $50M | — | — | — | — | — | — |
| Total liabilities | $503M | $462M | $402M | $396M | $857M | $996M | $1.1B | $1.0B | $878M | $743M |
| Shareholders' equity | $459M | $554M | $680M | $845M | $968M | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Net debt | $200M | $178M | $68M | -$77M | -$486M | -$349M | -$330M | -$468M | -$369M | -$197M |
Cash flow
Fiscal years, from Omnicell's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $50M | $25M | $104M | $145M | $186M | $232M | $78M | $181M | $188M | $127M |
| Capital spending | $13M | $15M | $24M | $16M | $23M | $29M | $48M | $41M | $36M | $40M |
| Free cash flow | $36M | $9M | $80M | $129M | $163M | $203M | $30M | $140M | $151M | $87M |
| Stock-based compensation | $20M | $22M | $29M | $34M | $45M | $53M | $68M | $55M | $39M | $45M |
| Share buybacks (net) | $0 | $0 | $0 | $0 | -$53M | $0 | -$52M | $0 | $0 | -$78M |
| Net borrowing | -$34M | -$44M | -$77M | -$90M | -$200M | $0 | $0 | — | — | — |
| Free cash flow margin | 5.2% | 1.3% | 10.2% | 14.4% | 18.3% | 17.9% | 2.3% | 12.2% | 13.6% | 7.3% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for OMCL.
Open OMCL in InvestinglyQuestions
What was Omnicell's revenue in 2025?
$1.2B in fiscal 2025, from its 10-K filing.
How much free cash flow does Omnicell generate?
$87M in fiscal 2025 (operating cash flow minus capital spending).
From Omnicell's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.